WordNet

having an (over)abundance of flesh; "he hadnt remembered how fat she was"
a soft greasy substance occurring in organic tissue and consisting of a mixture of lipids (mostly triglycerides); "pizza has too much fat"
marked by great fruitfulness; "fertile farmland"; "a fat land"; "a productive vineyard"; "rich soil" (同)fertile, productive, rich
lucrative; "a juicy contract"; "a nice fat job" (同)juicy
having a relatively large diameter; "a fat rope"
containing or composed of fat; "fatty food"; "fat tissue" (同)fat
a chronic disease interfering with the normal functioning of the liver; the major cause is chronic alcoholism (同)cirrhosis of the liver

PrepTutorEJDIC

『脂肪』,脂肪分 / (動物の)あぶら身 / (料理用の)油,ヘット / 肥満,太り過ぎ / 『太った』,肥満した / 『脂肪の多い』 / たっぷりとはいった,分厚い / もうかる / (土地が)肥えた / …‘を'太らせる / ふとる,肥える
脂肪質の,脂肪の多い / でぶ,太っちょ
肝硬変

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis.

Bajaj JS1.
Alimentary pharmacology & therapeutics.Aliment Pharmacol Ther.2016 Jan;43 Suppl 1:11-26. doi: 10.1111/apt.13435.
BACKGROUND: Progressive gut milieu (microbiota) changes occur in patients with cirrhosis and are associated with complications [e.g. hepatic encephalopathy (HE)].AIM: To examine the role of rifaximin in the management of HE and other complications of cirrhosis, including potential mechanisms of acti
PMID 26618922

Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.

Doycheva I1, Cui J1, Nguyen P1,2, Costa EA3, Hooker J3, Hofflich H4, Bettencourt R5, Brouha S6, Sirlin CB3, Loomba R1,2,5.
Alimentary pharmacology & therapeutics.Aliment Pharmacol Ther.2016 Jan;43(1):83-95. doi: 10.1111/apt.13405. Epub 2015 Sep 15.
BACKGROUND: Current guidelines do not recommend screening for non-alcoholic fatty liver disease (NAFLD) or advanced fibrosis. Patients with type 2 diabetes mellitus (T2DM) are known to be at increased risk for NAFLD and advanced fibrosis.AIM: To assess the feasibility in diabetics in a primary care
PMID 26369383

Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis.

Cengiz M1, Ozenirler S, Kocabiyik M.
European journal of gastroenterology & hepatology.Eur J Gastroenterol Hepatol.2016 Jan;28(1):57-63. doi: 10.1097/MEG.0000000000000502.
OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease and evaluation of fibrosis is important. We aimed to investigate the utility of serum β-trophin in NAFLD and its ability to predict liver fibrosis.PATIENTS AND METHODS: Serum samples of consecutive patients with b
PMID 26513612

正田純一,呉世昶,志田隆史,田中喜代次
体力科学 64(2), 217-226, 2015
… These days, the rapid increase in the number of adult people with abnormal liver function associated with obesity is largely attributed to an increase in the incidence of non-alcoholic fatty liver disease (NAFLD), a chronic liver disease accompanying fat accumulation. … NASH is a progressive disease leading to liver cirrhosis. …
NAID 130005063348

Long-Term Survival with Growth Hormone Replacement after Liver Transplantation of Pediatric Nonalcoholic Steatohepatitis Complicating Acquired Hypopituitarism

, , , , , , , ,
The Tohoku Journal of Experimental Medicine 235(1), 61-67, 2015
… Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD). … At age 15 years, he developed fatigue and dyspnea and was found to have liver cirrhosis secondary to NASH with severe hepatopulmonary syndrome. … Ten years after LDLT, fatty liver remains stable, although his body mass index has not been reduced. …
NAID 130004822429

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway

Ishikawa Hisashi,Takaki Akinobu,Tsuzaki Ryuichiro,Yasunaka Tetsuya,Koike Kazuko,Shimomura Yasuyuki,Seki Hiroyuki,Matsushita Hiroshi,Miyake Yasuhiro,Ikeda Fusao,Shiraha Hidenori,Nouso Kazuhiro,Yamamoto Kazuhide
PLoS ONE 9(7), 2014-07-01
… Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease characterized by lobular inflammation, hepatocellular ballooning, and fibrosis with an inherent risk for progression to cirrhosis and hepatocellular carcinoma (HCC). … Eight-week-old male STAM mice, a NASH-cirrhosis-hepatocarcinogenic model, were divided into 3 experimental groups and fed as follows: 1) high-fat diet (HFD) (control group); …
NAID 120005553912